1	CX3CR1-dependent	CX3CR1-dependent	B-NP	JJ	O	5	NMOD	17	dependent
2	subretinal	subretinal	I-NP	JJ	O	5	NMOD	-1
3	microglia	microglia	I-NP	NN	O	5	NMOD	-1
4	cell	cell	I-NP	NN	O	5	NMOD	-1
5	accumulation	accumulation	I-NP	NN	O	6	SUB	1	accumulation
6	is	be	B-VP	VBZ	O	0	ROOT	-1
7	associated	associate	I-VP	VBN	O	6	VC	16	associated
8	with	with	B-PP	IN	O	7	VMOD	-1
9	cardinal	cardinal	B-NP	JJ	O	10	NMOD	-1
10	features	feature	I-NP	NNS	O	8	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	age-related	age-related	B-NP	JJ	O	14	NMOD	-1
13	macular	macular	I-NP	JJ	O	14	NMOD	-1
14	degeneration	degeneration	I-NP	NN	O	11	PMOD	6	degeneration
15	.	.	O	.	O	6	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	role	role	I-NP	NN	O	17	SUB	16	role
3	of	of	B-PP	IN	O	2	NMOD	-1
4	retinal	retinal	B-NP	JJ	B-cell_type	6	NMOD	-1
5	microglial	microglial	I-NP	JJ	I-cell_type	6	NMOD	-1
6	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	-1
7	(	(	O	(	O	9	DEP	-1
8	MCs	MC	B-NP	NNS	B-cell_type	9	DEP	-1
9	)	)	O	)	O	6	NMOD	-1
10	in	in	B-PP	IN	O	2	NMOD	-1
11	age-related	age-related	B-NP	JJ	O	13	NMOD	-1
12	macular	macular	I-NP	JJ	O	13	NMOD	-1
13	degeneration	degeneration	I-NP	NN	O	10	PMOD	6	degeneration
14	(	(	O	(	O	16	DEP	-1
15	AMD	AMD	B-NP	NN	O	16	DEP	-1
16	)	)	O	)	O	13	NMOD	-1
17	is	be	B-VP	VBZ	O	0	ROOT	-1
18	unclear	unclear	B-ADJP	JJ	O	17	PRD	-1
19	.	.	O	.	O	17	P	-1

1	Here	Here	B-ADVP	RB	O	3	VMOD	-1
2	we	we	B-NP	PRP	O	3	SUB	-1
3	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	17	DEP	-1
5	all	all	B-NP	DT	O	7	NMOD	-1
6	retinal	retinal	I-NP	JJ	B-cell_type	7	NMOD	-1
7	MCs	MC	I-NP	NNS	I-cell_type	8	SUB	-1
8	express	express	B-VP	VBP	O	4	SBAR	9	express
9	CX3C	CX3C	B-NP	NN	B-protein	11	NMOD	-1
10	chemokine	chemokine	I-NP	NN	I-protein	11	NMOD	-1
11	receptor	receptor	I-NP	NN	I-protein	8	OBJ	-1
12	1	1	I-NP	CD	I-protein	11	NMOD	-1
13	(	(	O	(	O	15	DEP	-1
14	CX3CR1	CX3CR1	B-NP	NN	B-protein	15	DEP	-1
15	)	)	O	)	O	11	NMOD	-1
16	and	and	O	CC	O	17	DEP	-1
17	that	that	B-SBAR	IN	O	3	VMOD	-1
18	homozygosity	homozygosity	B-NP	NN	O	33	SUB	-1
19	for	for	B-PP	IN	O	18	NMOD	-1
20	the	the	B-NP	DT	O	23	NMOD	-1
21	CX3CR1	CX3CR1	I-NP	NN	B-DNA	23	NMOD	-1
22	M280	M280	I-NP	NN	I-DNA	23	NMOD	-1
23	allele	allele	I-NP	NN	I-DNA	19	PMOD	-1
24	,	,	O	,	O	23	P	-1
25	which	which	B-NP	WDT	O	23	NMOD	-1
26	is	be	B-VP	VBZ	O	25	SBAR	-1
27	associated	associate	I-VP	VBN	O	26	VC	0
28	with	with	B-PP	IN	O	27	VMOD	-1
29	impaired	impaired	B-NP	JJ	O	31	NMOD	18	impaired
30	cell	cell	I-NP	NN	O	31	NMOD	-1
31	migration	migration	I-NP	NN	O	28	PMOD	14	migration
32	,	,	O	,	O	18	P	-1
33	increases	increase	B-VP	VBZ	O	17	SBAR	0
34	the	the	B-NP	DT	O	35	NMOD	-1
35	risk	risk	I-NP	NN	O	33	OBJ	-1
36	of	of	B-PP	IN	O	35	NMOD	-1
37	AMD	AMD	B-NP	NN	B-protein	36	PMOD	-1
38	.	.	O	.	O	3	P	-1

1	In	In	B-PP	IN	O	0	ROOT	-1
2	humans	human	B-NP	NNS	O	1	PMOD	-1
3	with	with	B-PP	IN	O	2	NMOD	-1
4	AMD	AMD	B-NP	NN	O	3	PMOD	-1
5	,	,	O	,	O	1	VMOD	-1
6	MCs	MC	B-NP	NNS	B-cell_type	5	NMOD	-1
7	accumulated	accumulate	B-VP	VBN	O	6	NMOD	1	accumulated
8	in	in	B-PP	IN	O	7	VMOD	-1
9	the	the	B-NP	DT	O	11	NMOD	-1
10	subretinal	subretinal	I-NP	JJ	O	11	NMOD	-1
11	space	space	I-NP	NN	O	8	PMOD	-1
12	at	at	B-PP	IN	O	11	NMOD	-1
13	sites	site	B-NP	NNS	O	12	PMOD	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	retinal	retinal	B-NP	JJ	O	16	NMOD	-1
16	degeneration	degeneration	I-NP	NN	O	19	NMOD	6	degeneration
17	and	and	O	CC	O	19	NMOD	-1
18	choroidal	choroidal	B-NP	JJ	O	19	NMOD	-1
19	neovascularization	neovascularization	I-NP	NN	O	14	PMOD	3	neovascularization
20	(	(	O	(	O	22	DEP	-1
21	CNV	CNV	B-NP	NN	B-protein	22	DEP	3	CNV
22	)	)	O	)	O	19	NMOD	-1
23	.	.	O	.	O	6	P	-1

1	In	In	B-PP	IN	O	6	VMOD	-1
2	CX3CR1-deficient	CX3CR1-deficient	B-NP	JJ	O	3	NMOD	-1
3	mice	mouse	I-NP	NNS	O	1	PMOD	-1
4	,	,	O	,	O	6	P	-1
5	MCs	MC	B-NP	NNS	B-cell_type	6	SUB	-1
6	accumulated	accumulate	B-VP	VBD	O	0	ROOT	1	accumulated
7	subretinally	subretinally	B-ADVP	RB	O	6	VMOD	-1
8	with	with	B-PP	IN	O	6	VMOD	-1
9	age	age	B-NP	NN	O	12	NMOD	-1
10	and	and	I-NP	CC	O	12	NMOD	-1
11	albino	albino	I-NP	NN	O	12	NMOD	-1
12	background	background	I-NP	NN	O	8	PMOD	-1
13	and	and	B-PP	CC	O	8	PMOD	-1
14	after	after	B-PP	IN	O	8	PMOD	-1
15	laser	laser	B-NP	NN	O	16	NMOD	-1
16	impact	impact	I-NP	NN	O	14	PMOD	0
17	preceding	precede	B-VP	VBG	O	16	NMOD	-1
18	retinal	retinal	B-NP	JJ	O	19	NMOD	-1
19	degeneration	degeneration	I-NP	NN	O	17	OBJ	6	degeneration
20	.	.	O	.	O	6	P	-1

1	Raising	Raise	B-VP	VBG	O	8	SUB	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	albino	albino	I-NP	NN	O	4	NMOD	-1
4	mice	mouse	I-NP	NNS	O	1	OBJ	-1
5	in	in	B-PP	IN	O	1	VMOD	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	dark	dark	I-NP	NN	O	5	PMOD	-1
8	prevented	prevent	B-VP	VBD	O	0	ROOT	0
9	both	both	B-NP	DT	O	10	NMOD	-1
10	events	event	I-NP	NNS	O	8	OBJ	-1
11	.	.	O	.	O	8	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	appearance	appearance	I-NP	NN	O	7	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	lipid-bloated	lipid-bloated	B-NP	JJ	B-cell_type	6	NMOD	-1
5	subretinal	subretinal	I-NP	JJ	I-cell_type	6	NMOD	-1
6	MCs	MC	I-NP	NNS	I-cell_type	3	PMOD	-1
7	was	be	B-VP	VBD	O	19	VMOD	-1
8	drusen-like	drusen-like	B-ADJP	JJ	O	7	PRD	-1
9	on	on	B-PP	IN	O	8	AMOD	-1
10	funduscopy	funduscopy	B-NP	NN	O	9	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	senescent	senescent	B-NP	JJ	O	13	NMOD	-1
13	mice	mouse	I-NP	NNS	O	11	PMOD	-1
14	,	,	O	,	O	19	P	-1
15	and	and	O	CC	O	19	VMOD	-1
16	CX3CR1-dependent	CX3CR1-dependent	B-NP	JJ	O	18	NMOD	17	dependent
17	MC	MC	I-NP	NN	O	18	NMOD	-1
18	accumulation	accumulation	I-NP	NN	O	19	SUB	1	accumulation
19	was	be	B-VP	VBD	O	0	ROOT	-1
20	associated	associate	I-VP	VBN	O	19	VC	16	associated
21	with	with	B-PP	IN	O	20	VMOD	-1
22	an	an	B-NP	DT	O	23	NMOD	-1
23	exacerbation	exacerbation	I-NP	NN	O	21	PMOD	17	exacerbation
24	of	of	B-PP	IN	O	23	NMOD	-1
25	experimental	experimental	B-NP	JJ	O	26	NMOD	-1
26	CNV	CNV	I-NP	NN	O	24	PMOD	3	CNV
27	.	.	O	.	O	19	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	show	show	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	CX3CR1-dependent	CX3CR1-dependent	B-NP	JJ	O	6	NMOD	17	dependent
6	accumulation	accumulation	I-NP	NN	O	10	SUB	1	accumulation
7	of	of	B-PP	IN	O	6	NMOD	-1
8	subretinal	subretinal	B-NP	JJ	O	9	NMOD	-1
9	MCs	MC	I-NP	NNS	O	7	PMOD	-1
10	evokes	evoke	B-VP	VBZ	O	4	SBAR	-1
11	cardinal	cardinal	B-NP	JJ	O	12	NMOD	-1
12	features	feature	I-NP	NNS	O	10	OBJ	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	AMD	AMD	B-NP	NN	B-protein	13	PMOD	-1
15	.	.	O	.	O	3	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	findings	finding	I-NP	NNS	O	3	SUB	-1
3	reveal	reveal	B-VP	VBP	O	0	ROOT	-1
4	what	what	B-NP	WP	O	3	VMOD	-1
5	we	we	B-NP	PRP	O	6	SUB	-1
6	believe	believe	B-VP	VBP	O	4	SBAR	-1
7	to	to	I-VP	TO	O	8	VMOD	-1
8	be	be	I-VP	VB	O	6	VMOD	-1
9	a	a	B-NP	DT	O	12	NMOD	-1
10	novel	novel	I-NP	JJ	O	12	NMOD	-1
11	pathogenic	pathogenic	I-NP	JJ	O	12	NMOD	-1
12	process	process	I-NP	NN	O	8	PRD	-1
13	with	with	B-PP	IN	O	12	NMOD	-1
14	important	important	B-NP	JJ	O	15	NMOD	0
15	implications	implication	I-NP	NNS	O	13	PMOD	-1
16	for	for	B-PP	IN	O	15	NMOD	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	development	development	I-NP	NN	O	16	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	-1
20	new	new	B-NP	JJ	O	21	NMOD	-1
21	therapies	therapy	I-NP	NNS	O	19	PMOD	0
22	for	for	B-PP	IN	O	21	NMOD	-1
23	AMD	AMD	B-NP	NN	O	22	PMOD	-1
